Alzheimer's disease biomarker states

Affiliations

¹ Department of Psychiatry and Neuropsychology, Institute of Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, 6200 MD, Netherlands. Electronic address: s.vos@maastrichtuniversity.nl.
² Department of Neurology, Alzheimer's Disease Research Center, Hope Center for Neurological Disorders, Washington University School of Medicine, Saint Louis, MO, USA.

Comment

Stephanie J B Vos et al. Lancet Neurol. 2016 Jan.

. 2016 Jan;15(1):25-6.

doi: 10.1016/S1474-4422(15)00335-X. Epub 2015 Nov 18.

¹ Department of Psychiatry and Neuropsychology, Institute of Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, 6200 MD, Netherlands. Electronic address: s.vos@maastrichtuniversity.nl.
² Department of Neurology, Alzheimer's Disease Research Center, Hope Center for Neurological Disorders, Washington University School of Medicine, Saint Louis, MO, USA.

No abstract available

Comment on

Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study.
Jack CR Jr, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Mielke MM, Vemuri P, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC. Jack CR Jr, et al. Lancet Neurol. 2016 Jan;15(1):56-64. doi: 10.1016/S1474-4422(15)00323-3. Epub 2015 Nov 18. Lancet Neurol. 2016. PMID: 26597325 Free PMC article.